Related Experiment Video
Updated: May 10, 2026

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
VPS13B maintains lysosomal homeostasis through regulation of TFEB
Soo-Kyeong Lee1, Semin Park1, Min-Young Yeom1
1Department of Biological Sciences and Biotechnology, College of Life Sciences and Nanotechnology, Hannam University, 1646 Yuseong-daero, Yuseong-gu, Daejeon, 34054, Korea.
Insights
VPS13B protein deficiency impairs lysosomal homeostasis in Cohen syndrome (CS). This study reveals VPS13B
Area of Science:
- Cell Biology
- Genetics
- Neuroscience
Background:
- Cohen syndrome (CS) is a rare autosomal recessive neurodevelopmental disorder.
- VPS13B's role in phosphatidylinositol 4-phosphate (PI4P) transport and mitochondrial fission was previously established.
- The precise molecular mechanisms underlying CS pathology remain incompletely understood.
Purpose of the Study:
- To investigate the role of VPS13B in lysosomal homeostasis.
- To elucidate the contribution of VPS13B dysfunction to Cohen syndrome pathogenesis.
Main Methods:
- VPS13B knockout (KO) HeLa cells and induced neurons from CS patient iPSCs were utilized.
- Bulk RNA sequencing and quantitative RT-PCR were performed to analyze gene expression.
- Lysosomal distribution, acidification, and TFEB (Transcription Factor EB) activity were assessed.
Main Results:
- VPS13B KO cells displayed aberrant lysosomal distribution and reduced LAMP1-positive lysosomes.
- Downregulation of lysosome-related genes, including those for acidification and biogenesis, was observed.
- VPS13B deficiency impaired lysosomal acidification and altered TFEB regulation.
Conclusions:
- VPS13B is identified as a crucial regulator of lysosomal homeostasis.
- VPS13B dysfunction contributes to Cohen syndrome pathology by disrupting lysosomal function.
- These findings offer new insights into the molecular basis of Cohen syndrome.
Abstract:
Cohen syndrome (CS) is a rare autosomal recessive neurodevelopmental disorder characterized by intellectual disability, microcephaly, retinal dystrophy, and neutropenia. We previously demonstrated that VPS13B mediates phosphatidylinositol 4-phosphate (PI4P) transport to promote mitochondrial fission. Here, we identify VPS13B as a regulator of lysosomal homeostasis. VPS13B knockout (KO) HeLa cells exhibited aberrant lysosomal distribution and reduction in LAMP1-positive lysosomes. Bulk RNA sequencing revealed coordinated downregulation of lysosome-related genes, including genes required for acidification and lysosome biogenesis, which was confirmed by quantitative RT-PCR. Consistent with these transcriptional changes, VPS13B KO significantly reduced the abundance of LysoTracker-positive acidic compartments. Induced neurons derived from CS patient iPSCs recapitulated the loss of acidic lysosomal compartments, supporting disease relevance. Mechanistically, VPS13B KO altered TFEB mRNA levels and modestly increased the basal nuclear-to-cytoplasmic (N/C) ratio of endogenous TFEB, but blunted its further increase upon Torin1 treatment. Together, these findings identify VPS13B as a regulator of lysosomal homeostasis and provide insight into how VPS13B deficiency may contribute to Cohen syndrome pathology.
Related Concept Videos
Intralumenal Vesicles and Multivesicular Bodies
Lysosomal Hydrolases
The Early Endosome: Endocytosis of Transferrin
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Lysosomes
Lysosomes

